{"id":"https://openalex.org/W4398208291","doi":"https://doi.org/10.1002/prp2.1193","title":"Population pharmacokinetics and dose rationale for aciclovir in term and pre\u2010term neonates with herpes","display_name":"Population pharmacokinetics and dose rationale for aciclovir in term and pre\u2010term neonates with herpes","publication_year":2024,"publication_date":"2024-05-22","ids":{"openalex":"https://openalex.org/W4398208291","doi":"https://doi.org/10.1002/prp2.1193","pmid":"https://pubmed.ncbi.nlm.nih.gov/38775304","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11110484"},"language":"en","primary_location":{"id":"doi:10.1002/prp2.1193","doi":"https://doi.org/10.1002/prp2.1193","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.1193","pdf_url":null,"source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research &amp; Perspectives","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1002/prp2.1193","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079418262","display_name":"Salvatore D\u02bcAgate","orcid":"https://orcid.org/0000-0001-5328-4834","observed_orcids":["https://orcid.org/0000-0001-5328-4834"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"S. D'Agate","raw_affiliation_strings":["Clinical Pharmacology &amp; Therapeutics Group University College London London UK"],"raw_orcid":"https://orcid.org/0000-0001-5328-4834","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology &amp; Therapeutics Group University College London London UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113224049","display_name":"D. Ruiz Gabarre","orcid":"https://orcid.org/0000-0003-4109-1191","observed_orcids":["https://orcid.org/0000-0003-4109-1191"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Ruiz\u00a0Gabarre","raw_affiliation_strings":["Clinical Pharmacology &amp; Therapeutics Group University College London London UK"],"raw_orcid":"https://orcid.org/0000-0003-4109-1191","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology &amp; Therapeutics Group University College London London UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081960928","display_name":"Oscar E. Della Pasqua","orcid":"https://orcid.org/0000-0002-6211-1430","observed_orcids":["https://orcid.org/0000-0002-6211-1430"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"O. Della\u00a0Pasqua","raw_affiliation_strings":["Clinical Pharmacology &amp; Therapeutics Group University College London London UK"],"raw_orcid":"https://orcid.org/0000-0002-6211-1430","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology &amp; Therapeutics Group University College London London UK","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5079418262"],"corresponding_institution_ids":["https://openalex.org/I45129253"],"apc_list":{"value":4040,"currency":"USD","value_usd":4040},"apc_paid":{"value":4040,"currency":"USD","value_usd":4040},"fwci":2.6339,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.88783108,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"12","issue":"3","first_page":"e1193","last_page":"e1193"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acyclovir","display_name":"acyclovir","score":0.9940000176429749},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.8040000200271606},{"id":"https://openalex.org/keywords/newborns","display_name":"neonates","score":0.7789999842643738},{"id":"https://openalex.org/keywords/preterm-infants","display_name":"preterm infants","score":0.8420000076293945},{"id":"https://openalex.org/keywords/herpes-simplex-virus-infection","display_name":"herpes simplex","score":0.9380000233650208},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5619999766349792},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.6779999732971191},{"id":"https://openalex.org/keywords/clearance","display_name":"clearance","score":0.7390000224113464},{"id":"https://openalex.org/keywords/covariates","display_name":"covariates","score":0.4909999966621399},{"id":"https://openalex.org/keywords/one-compartment-model","display_name":"one-compartment model","score":0.6309999823570251},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.3409999907016754},{"id":"https://openalex.org/keywords/neonatal-dosing","display_name":"neonatal dosing","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2779450786","wikidata":"https://www.wikidata.org/wiki/Q147101","display_name":"Aciclovir","level":5,"score":0.9320671558380127},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8429592251777649},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6991998553276062},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6664537191390991},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6457681059837341},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6029587388038635},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.43795543909072876},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39033037424087524},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.347638338804245},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2695910334587097},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26500654220581055},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.17560917139053345},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.15267512202262878},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007231","descriptor_name":"Infant, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/prp2.1193","doi":"https://doi.org/10.1002/prp2.1193","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.1193","pdf_url":null,"source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research &amp; Perspectives","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11110484","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11110484","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11110484/pdf/PRP2-12-e1193.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacol Res Perspect","raw_type":"Text"},{"id":"pmid:38775304","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38775304","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology research & perspectives","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10189524","doi":null,"is_oa":true,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10189524/","pdf_url":"https://discovery.ucl.ac.uk/id/eprint/10189524/10/Della%20Pasqua_Pharmacology%20Res%20%20%20Perspec%20-%202024%20-%20D%27Agate%20-%20Population%20pharmacokinetics%20and%20dose%20rationale%20for%20aciclovir%20in%20term%20and.pdf","source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology Research &amp; Perspectives , 12 (3) , Article e1193. (2024)","raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:ab83317bd1464d8b935380ee8ce8d5fc","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ab83317bd1464d8b935380ee8ce8d5fc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology Research & Perspectives, Vol 12, Iss 3, Pp n/a-n/a (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/prp2.1193","doi":"https://doi.org/10.1002/prp2.1193","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.1193","pdf_url":null,"source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research &amp; Perspectives","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4398208291.pdf","grobid_xml":"https://content.openalex.org/works/W4398208291.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W838922786","https://openalex.org/W1550111394","https://openalex.org/W1552675352","https://openalex.org/W1566473841","https://openalex.org/W1965782495","https://openalex.org/W1978196389","https://openalex.org/W1983033150","https://openalex.org/W1989205263","https://openalex.org/W1992094709","https://openalex.org/W1998827428","https://openalex.org/W2016817909","https://openalex.org/W2018196928","https://openalex.org/W2049734705","https://openalex.org/W2051807557","https://openalex.org/W2072550989","https://openalex.org/W2089295053","https://openalex.org/W2093073135","https://openalex.org/W2094904225","https://openalex.org/W2098995719","https://openalex.org/W2106360179","https://openalex.org/W2108794518","https://openalex.org/W2110116923","https://openalex.org/W2110913773","https://openalex.org/W2117702644","https://openalex.org/W2122855609","https://openalex.org/W2127472356","https://openalex.org/W2140244811","https://openalex.org/W2141205716","https://openalex.org/W2151651605","https://openalex.org/W2164141537","https://openalex.org/W2167807568","https://openalex.org/W2286127041","https://openalex.org/W2344000208","https://openalex.org/W2510513174","https://openalex.org/W2607974207","https://openalex.org/W2626815554","https://openalex.org/W2771328536","https://openalex.org/W2897764170","https://openalex.org/W2953732145","https://openalex.org/W2987002164","https://openalex.org/W3044953051","https://openalex.org/W3090077807","https://openalex.org/W3161934566","https://openalex.org/W3189836215","https://openalex.org/W3194319661","https://openalex.org/W4206089446","https://openalex.org/W4220811332","https://openalex.org/W4236050395","https://openalex.org/W4283275347","https://openalex.org/W4297674469","https://openalex.org/W6955054332"],"related_works":["https://openalex.org/W2068172262","https://openalex.org/W2141205716","https://openalex.org/W1989452277","https://openalex.org/W2018934467","https://openalex.org/W4223962536","https://openalex.org/W1972309215","https://openalex.org/W4415379442","https://openalex.org/W4400042229","https://openalex.org/W1965782495","https://openalex.org/W2317068699"],"abstract_inverted_index":{"Abstract":[0],"Aciclovir":[1,137],"is":[2,20],"considered":[3],"the":[4,21,35,46,56,68,80,127,159,221],"first\u2010line":[5],"treatment":[6],"against":[7],"Herpes":[8],"simplex":[9],"virus":[10],"(HSV)":[11],"infections":[12],"in":[13,26,79,183],"new\u2010borns":[14],"and":[15,76,107,117,150,167,227,240],"infants.":[16],"As":[17],"renal":[18,50,118,241],"excretion":[19],"major":[22],"route":[23],"of":[24,37,48,62,70,115,129,161,196,223],"elimination,":[25],"renally\u2010impaired":[27],"patients,":[28],"aciclovir":[29,71,232],"doses":[30],"are":[31],"adjusted":[32],"according":[33],"to":[34,45,55,66,125,132,180,231,235],"degree":[36],"impairment.":[38],"However,":[39],"limited":[40],"attention":[41],"has":[42],"been":[43],"given":[44],"implications":[47],"immature":[49],"function":[51,242],"or":[52,188],"dysfunction":[53],"due":[54],"viral":[57],"disease":[58,77],"itself.":[59],"The":[60],"aim":[61],"this":[63,205],"investigation":[64],"was":[65,139,198,217,233],"characterize":[67],"pharmacokinetics":[69,138],"taking":[72],"into":[73],"account":[74],"maturation":[75,116],"processes":[78],"neonatal":[81],"population.":[82],"Pharmacokinetic":[83],"data":[84,131],"obtained":[85],"from":[86,135,178],"2":[87],"previously":[88],"published":[89],"clinical":[90],"trials":[91],"(n":[92],"=":[93],"28)":[94],"were":[95,111,122,154],"analyzed":[96],"using":[97],"a":[98,142,170],"nonlinear":[99],"mixed":[100],"effects":[101,222],"modeling":[102],"approach.":[103],"Post\u2010menstrual":[104],"age":[105],"(PMA)":[106],"creatinine":[108],"clearance":[109,176],"(CLCR)":[110],"assessed":[112],"as":[113],"descriptors":[114],"function.":[119,229],"Simulation":[120],"scenarios":[121],"also":[123],"implemented":[124],"illustrate":[126],"use":[128],"pharmacokinetic":[130],"extrapolate":[133],"efficacy":[134],"adults.":[136],"described":[140],"by":[141,207],"one\u2010compartment":[143],"model":[144,215],"with":[145,185,201,237],"first\u2010order":[146],"elimination.":[147],"Body":[148],"weight":[149],"diagnosis":[151],"(systemic":[152],"infection)":[153],"statistically":[155],"significant":[156,171],"covariates":[157],"on":[158,173],"volume":[160,195],"distribution,":[162],"whereas":[163],"body":[164],"weight,":[165],"CLCR":[166],"PMA":[168,186,239],"had":[169],"effect":[172],"clearance.":[174],"Median":[175],"varied":[177],"0.2":[179],"1.0":[181],"L/h":[182],"subjects":[184],"<34":[187],"\u226534":[189],"weeks,":[190],"respectively.":[191],"Population":[192],"estimate":[193],"for":[194,248],"distribution":[197],"1.93":[199],"L":[200],"systemic":[202],"infection":[203],"increasing":[204],"value":[206],"almost":[208],"3\u2010fold":[209],"(2.67":[210],"times":[211],"higher).":[212],"A":[213],"suitable":[214],"parameterization":[216],"identified,":[218],"which":[219],"discriminates":[220],"developmental":[224],"growth,":[225],"maturation,":[226],"organ":[228],"Exposure":[230],"found":[234],"increase":[236],"decreasing":[238],"(CLCR),":[243],"suggesting":[244],"different":[245],"dosing":[246],"requirement":[247],"pre\u2010term":[249],"neonates.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-23T00:00:00"}